Open Comparative Study With a Cross-Over According to Patients'Preference Receiving Xeloda or UFT With Folinic Acid in Advanced or Metastatic Colo-Rectal Cancer.

Trial Profile

Open Comparative Study With a Cross-Over According to Patients'Preference Receiving Xeloda or UFT With Folinic Acid in Advanced or Metastatic Colo-Rectal Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Jul 2012

At a glance

  • Drugs Capecitabine (Primary) ; Folinic acid (Primary) ; Tegafur/uracil (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms COLOCROSS
  • Most Recent Events

    • 20 Jul 2012 Actual end date (1 Sep 2011) added as reported by ClinicalTrials.gov.
    • 01 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov..
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top